机译:β-巯基乙醇的添加是使用QIAsymphony技术进行高质量RNA分离的先决条件,如通过检测血液系统恶性肿瘤中的分子畸变所证明的那样
Department of Hematology, Erasmus University Medical Center Rotterdam,Rotterdam,The Netherlands;
Department of Hematology, Erasmus University Medical Center Rotterdam,Rotterdam,The Netherlands;
Department of Hematology, Erasmus University Medical Center Rotterdam,Rotterdam,The Netherlands;
Department of Hematology, Erasmus University Medical Center Rotterdam,Rotterdam,The Netherlands;
Department of Hematology, Erasmus University Medical Center Rotterdam,Rotterdam,The Netherlands;
Department of Hematology, Erasmus University Medical Center Rotterdam,Rotterdam,The Netherlands;
Department of Hematology, Erasmus University Medical Center Rotterdam,Rotterdam,The Netherlands;
Department of Hematology, Erasmus University Medical Center Rotterdam,Rotterdam,The Netherlands;
Department of Hematology Faculty Building Eel391a, Erasmus University Medical Center Rotterdam Dr. Molewaterplein 50 3015 GE Rotterdam Z-H The Netherlands;
机译:使用下一代测序(NGS)技术进行有针对性的RNA测序(RNA-Seq)分析的Archer FusionPlex检测血液系统恶性肿瘤中的融合转录本
机译:血液恶性肿瘤中染色体畸变的快速FISH检测和半自动图像分析
机译:血液恶性肿瘤中的MicroRNA和非编码RNA:分子,临床和治疗意义
机译:用于快速分离和检测DNA / RNA /外孔生物标志物的系统:“样品回答分子和传染性诊断” - (PPT)
机译:通过新技术对dna和rna标记物的研究表明,DNA含量在肿瘤中具有肿瘤内异质性和长期的非编码RNA畸变
机译:PNAS Plus:分子靶向药物组合对骨髓和淋巴来源的血液系统恶性肿瘤具有选择性有效性
机译:分子靶向药物组合表明了骨髓和淋巴衍生的血液学恶性肿瘤的选择性有效性